lobbying_filings_raw: fbced4f7-d1a5-4ea2-acce-dedd13a1eb43
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| fbced4f7-d1a5-4ea2-acce-dedd13a1eb43 | Q3 | 8511 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 112847 | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE) | 2019 | third_quarter | 2019-10-16T10:56:45.187000-04:00 | 40000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/fbced4f7-d1a5-4ea2-acce-dedd13a1eb43/", "filing_uuid": "fbced4f7-d1a5-4ea2-acce-dedd13a1eb43", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2019, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/fbced4f7-d1a5-4ea2-acce-dedd13a1eb43/print/", "filing_document_content_type": "text/html", "income": "40000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Katina L. Pierce", "dt_posted": "2019-10-16T10:56:45.187000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "600 Maryland Avenue, SW", "registrant_address_2": "SUITE 835W", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20024", "registrant": {"id": 8511, "url": "https://lda.senate.gov/api/v1/registrants/8511/", "house_registrant_id": 31321, "name": "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", "description": "Consultant firm", "address_1": "600 Maryland Avenue SW", "address_2": "Suite 220E", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20024", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "KATINA PIERCE", "contact_telephone": "+1 202-484-1100", "dt_updated": "2026-01-09T10:20:33.802241-05:00"}, "client": {"id": 112847, "url": "https://lda.senate.gov/api/v1/clients/112847/", "client_id": 1005204, "name": "GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (TB ALLIANCE)", "general_description": "Tuberculosis non-profit drug development company", "client_government_entity": false, "client_self_select": null, "state": "NY", "state_display": "New York", "country": "US", "country_display": "United States of America", "ppb_state": "NY", "ppb_state_display": "New York", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2018-03-01"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "US role in TB research and development\nS 839/HR 3080, The Comprehensive TB Elimination Act\nS 2438, The End TB Now Act of 2019", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66841, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": null, "last_name": "WILL MORTON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67930, "prefix": null, "prefix_display": null, "first_name": "CELIA", "nickname": null, "middle_name": null, "last_name": "HAGAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "FOR", "general_issue_code_display": "Foreign Relations", "description": "USAID tuberculosis program and research for new TB drugs\nReauthorization of USAID TB program", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66841, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": null, "last_name": "WILL MORTON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67930, "prefix": null, "prefix_display": null, "first_name": "CELIA", "nickname": null, "middle_name": null, "last_name": "HAGAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Report language and funding for TB programs at USAID, HHS and DoD", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66841, "prefix": null, "prefix_display": null, "first_name": "ERIN", "nickname": null, "middle_name": null, "last_name": "WILL MORTON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 67930, "prefix": null, "prefix_display": null, "first_name": "CELIA", "nickname": null, "middle_name": null, "last_name": "HAGAN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |